Article Details

FDA Designated Approved Bispecific Antibodies Offers USD 20 Billion Opportunity

Retrieved on: 2021-08-04 10:18:45

Tags for this article:

Click the tags to see associated articles and topics

FDA Designated Approved Bispecific Antibodies Offers USD 20 Billion Opportunity. View article details on hiswai:

Excerpt

... of monoclonal antibodies, increasing mortality rate due to cancer types and increasing cases of deaths due to development of adverse side-effects.

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up